The politics of personalised medicine: pharmacogenetics in the clinic
Pharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their ar...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge
Cambridge University Press
2004
|
| Schriftenreihe: | Cambridge studies in society and the life sciences
|
| Schlagworte: | |
| Online-Zugang: | BSB01 UBG01 Volltext |
| Zusammenfassung: | Pharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their arguments are beginning to influence policy debates. Based on interviews with clinicians, researchers, regulators and company representatives, this book explores the impact of pharmacogenetics on clinical practice, following two cases of personalised medicine as they make their way from the laboratory to the clinic. It highlights the significant differences between the views of supporters of pharmacogenetics in industry and those who use the technology at the clinical 'coal face'. Theoretically, this work builds on the developing area of the sociology of socio-technical expectations, highlighting the way in which promoters of new technologies build expectations around it, through citation and the creation of technological visions |
| Beschreibung: | Title from publisher's bibliographic system (viewed on 05 Oct 2015) |
| Beschreibung: | 1 online resource (vii, 208 pages) |
| ISBN: | 9780511489136 |
| DOI: | 10.1017/CBO9780511489136 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043921336 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 161202s2004 |||| o||u| ||||||eng d | ||
| 020 | |a 9780511489136 |c Online |9 978-0-511-48913-6 | ||
| 024 | 7 | |a 10.1017/CBO9780511489136 |2 doi | |
| 035 | |a (ZDB-20-CBO)CR9780511489136 | ||
| 035 | |a (OCoLC)704550199 | ||
| 035 | |a (DE-599)BVBBV043921336 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-473 | ||
| 082 | 0 | |a 615.5/8 |2 22 | |
| 100 | 1 | |a Hedgecoe, Adam |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a The politics of personalised medicine |b pharmacogenetics in the clinic |c Adam Hedgecoe |
| 264 | 1 | |a Cambridge |b Cambridge University Press |c 2004 | |
| 300 | |a 1 online resource (vii, 208 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Cambridge studies in society and the life sciences | |
| 500 | |a Title from publisher's bibliographic system (viewed on 05 Oct 2015) | ||
| 505 | 8 | |a Personalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political | |
| 520 | |a Pharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their arguments are beginning to influence policy debates. Based on interviews with clinicians, researchers, regulators and company representatives, this book explores the impact of pharmacogenetics on clinical practice, following two cases of personalised medicine as they make their way from the laboratory to the clinic. It highlights the significant differences between the views of supporters of pharmacogenetics in industry and those who use the technology at the clinical 'coal face'. Theoretically, this work builds on the developing area of the sociology of socio-technical expectations, highlighting the way in which promoters of new technologies build expectations around it, through citation and the creation of technological visions | ||
| 650 | 4 | |a Gesellschaft | |
| 650 | 4 | |a Pharmacogenetics / Social aspects | |
| 650 | 0 | 7 | |a Trastuzumab |0 (DE-588)4661821-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Brustkrebs |0 (DE-588)4008528-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Soziologie |0 (DE-588)4077624-4 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Medizin |0 (DE-588)4038243-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Tacrin |0 (DE-588)4415047-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakogenetik |0 (DE-588)4271255-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wissenschaftsentwicklung |0 (DE-588)4079355-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 0 | 1 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 0 | 2 | |a Wissenschaftsentwicklung |0 (DE-588)4079355-2 |D s |
| 689 | 0 | 3 | |a Soziologie |0 (DE-588)4077624-4 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a Brustkrebs |0 (DE-588)4008528-4 |D s |
| 689 | 1 | 1 | |a Trastuzumab |0 (DE-588)4661821-1 |D s |
| 689 | 1 | 2 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 1 | 3 | |a Wissenschaftsentwicklung |0 (DE-588)4079355-2 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 689 | 2 | 0 | |a Pharmakogenetik |0 (DE-588)4271255-5 |D s |
| 689 | 2 | 1 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 2 | 2 | |a Wissenschaftsentwicklung |0 (DE-588)4079355-2 |D s |
| 689 | 2 | 3 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 2 | |8 3\p |5 DE-604 | |
| 689 | 3 | 0 | |a Alzheimerkrankheit |0 (DE-588)4112510-1 |D s |
| 689 | 3 | 1 | |a Tacrin |0 (DE-588)4415047-7 |D s |
| 689 | 3 | 2 | |a Medizin |0 (DE-588)4038243-6 |D s |
| 689 | 3 | 3 | |a Wissenschaftsentwicklung |0 (DE-588)4079355-2 |D s |
| 689 | 3 | |8 4\p |5 DE-604 | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-60265-5 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druckausgabe |z 978-0-521-84177-1 |
| 856 | 4 | 0 | |u https://doi.org/10.1017/CBO9780511489136 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-20-CBO | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029330419 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511489136 |l BSB01 |p ZDB-20-CBO |q BSB_PDA_CBO |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.1017/CBO9780511489136 |l UBG01 |p ZDB-20-CBO |q UBG_PDA_CBO |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804176843380621312 |
|---|---|
| any_adam_object | |
| author | Hedgecoe, Adam |
| author_facet | Hedgecoe, Adam |
| author_role | aut |
| author_sort | Hedgecoe, Adam |
| author_variant | a h ah |
| building | Verbundindex |
| bvnumber | BV043921336 |
| collection | ZDB-20-CBO |
| contents | Personalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political |
| ctrlnum | (ZDB-20-CBO)CR9780511489136 (OCoLC)704550199 (DE-599)BVBBV043921336 |
| dewey-full | 615.5/8 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.5/8 |
| dewey-search | 615.5/8 |
| dewey-sort | 3615.5 18 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| doi_str_mv | 10.1017/CBO9780511489136 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05084nmm a2200829zc 4500</leader><controlfield tag="001">BV043921336</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">161202s2004 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780511489136</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-511-48913-6</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1017/CBO9780511489136</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-20-CBO)CR9780511489136</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)704550199</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043921336</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-473</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.5/8</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hedgecoe, Adam</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The politics of personalised medicine</subfield><subfield code="b">pharmacogenetics in the clinic</subfield><subfield code="c">Adam Hedgecoe</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (vii, 208 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cambridge studies in society and the life sciences</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Title from publisher's bibliographic system (viewed on 05 Oct 2015)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Personalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Pharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their arguments are beginning to influence policy debates. Based on interviews with clinicians, researchers, regulators and company representatives, this book explores the impact of pharmacogenetics on clinical practice, following two cases of personalised medicine as they make their way from the laboratory to the clinic. It highlights the significant differences between the views of supporters of pharmacogenetics in industry and those who use the technology at the clinical 'coal face'. Theoretically, this work builds on the developing area of the sociology of socio-technical expectations, highlighting the way in which promoters of new technologies build expectations around it, through citation and the creation of technological visions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gesellschaft</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacogenetics / Social aspects</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Trastuzumab</subfield><subfield code="0">(DE-588)4661821-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Soziologie</subfield><subfield code="0">(DE-588)4077624-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tacrin</subfield><subfield code="0">(DE-588)4415047-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wissenschaftsentwicklung</subfield><subfield code="0">(DE-588)4079355-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Wissenschaftsentwicklung</subfield><subfield code="0">(DE-588)4079355-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Soziologie</subfield><subfield code="0">(DE-588)4077624-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Brustkrebs</subfield><subfield code="0">(DE-588)4008528-4</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Trastuzumab</subfield><subfield code="0">(DE-588)4661821-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Wissenschaftsentwicklung</subfield><subfield code="0">(DE-588)4079355-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Pharmakogenetik</subfield><subfield code="0">(DE-588)4271255-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Wissenschaftsentwicklung</subfield><subfield code="0">(DE-588)4079355-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">Alzheimerkrankheit</subfield><subfield code="0">(DE-588)4112510-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="1"><subfield code="a">Tacrin</subfield><subfield code="0">(DE-588)4415047-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="2"><subfield code="a">Medizin</subfield><subfield code="0">(DE-588)4038243-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2="3"><subfield code="a">Wissenschaftsentwicklung</subfield><subfield code="0">(DE-588)4079355-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-60265-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druckausgabe</subfield><subfield code="z">978-0-521-84177-1</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1017/CBO9780511489136</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-20-CBO</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029330419</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511489136</subfield><subfield code="l">BSB01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">BSB_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1017/CBO9780511489136</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-20-CBO</subfield><subfield code="q">UBG_PDA_CBO</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043921336 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:38:37Z |
| institution | BVB |
| isbn | 9780511489136 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029330419 |
| oclc_num | 704550199 |
| open_access_boolean | |
| owner | DE-12 DE-473 DE-BY-UBG |
| owner_facet | DE-12 DE-473 DE-BY-UBG |
| physical | 1 online resource (vii, 208 pages) |
| psigel | ZDB-20-CBO ZDB-20-CBO BSB_PDA_CBO ZDB-20-CBO UBG_PDA_CBO |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Cambridge University Press |
| record_format | marc |
| series2 | Cambridge studies in society and the life sciences |
| spelling | Hedgecoe, Adam Verfasser aut The politics of personalised medicine pharmacogenetics in the clinic Adam Hedgecoe Cambridge Cambridge University Press 2004 1 online resource (vii, 208 pages) txt rdacontent c rdamedia cr rdacarrier Cambridge studies in society and the life sciences Title from publisher's bibliographic system (viewed on 05 Oct 2015) Personalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political Pharmacogenetics, the use of genetic testing to prescribe and develop drugs, has been hailed as a revolutionary development for the pharmaceutical industry and modern medicine. Supporters of 'personalised medicine' claim the result will be safer, cheaper, more effective drugs, and their arguments are beginning to influence policy debates. Based on interviews with clinicians, researchers, regulators and company representatives, this book explores the impact of pharmacogenetics on clinical practice, following two cases of personalised medicine as they make their way from the laboratory to the clinic. It highlights the significant differences between the views of supporters of pharmacogenetics in industry and those who use the technology at the clinical 'coal face'. Theoretically, this work builds on the developing area of the sociology of socio-technical expectations, highlighting the way in which promoters of new technologies build expectations around it, through citation and the creation of technological visions Gesellschaft Pharmacogenetics / Social aspects Trastuzumab (DE-588)4661821-1 gnd rswk-swf Brustkrebs (DE-588)4008528-4 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Soziologie (DE-588)4077624-4 gnd rswk-swf Medizin (DE-588)4038243-6 gnd rswk-swf Tacrin (DE-588)4415047-7 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 gnd rswk-swf Wissenschaftsentwicklung (DE-588)4079355-2 gnd rswk-swf Alzheimerkrankheit (DE-588)4112510-1 gnd rswk-swf Pharmakogenetik (DE-588)4271255-5 s Medizin (DE-588)4038243-6 s Wissenschaftsentwicklung (DE-588)4079355-2 s Soziologie (DE-588)4077624-4 s 1\p DE-604 Brustkrebs (DE-588)4008528-4 s Trastuzumab (DE-588)4661821-1 s 2\p DE-604 Gesundheitspolitik (DE-588)4113743-7 s 3\p DE-604 Alzheimerkrankheit (DE-588)4112510-1 s Tacrin (DE-588)4415047-7 s 4\p DE-604 Erscheint auch als Druckausgabe 978-0-521-60265-5 Erscheint auch als Druckausgabe 978-0-521-84177-1 https://doi.org/10.1017/CBO9780511489136 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Hedgecoe, Adam The politics of personalised medicine pharmacogenetics in the clinic Personalised medicine : a revolution in healthcare -- Pharacogenetics, expectation and promissory science -- Genetics, moral risk and professional resistance -- Clinical resistance to Alzheimer's pharmacogenetics -- Research, industry and pharamacogenetic literacy -- Engineering the clinic : getting personalised medicine into practice -- The fourth hurdle : cost-effectiveness and the funding of pharmacogenetics -- Disappointment and disclosure in the pharmacogenetic clinic -- The personalised is political Gesellschaft Pharmacogenetics / Social aspects Trastuzumab (DE-588)4661821-1 gnd Brustkrebs (DE-588)4008528-4 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Soziologie (DE-588)4077624-4 gnd Medizin (DE-588)4038243-6 gnd Tacrin (DE-588)4415047-7 gnd Pharmakogenetik (DE-588)4271255-5 gnd Wissenschaftsentwicklung (DE-588)4079355-2 gnd Alzheimerkrankheit (DE-588)4112510-1 gnd |
| subject_GND | (DE-588)4661821-1 (DE-588)4008528-4 (DE-588)4113743-7 (DE-588)4077624-4 (DE-588)4038243-6 (DE-588)4415047-7 (DE-588)4271255-5 (DE-588)4079355-2 (DE-588)4112510-1 |
| title | The politics of personalised medicine pharmacogenetics in the clinic |
| title_auth | The politics of personalised medicine pharmacogenetics in the clinic |
| title_exact_search | The politics of personalised medicine pharmacogenetics in the clinic |
| title_full | The politics of personalised medicine pharmacogenetics in the clinic Adam Hedgecoe |
| title_fullStr | The politics of personalised medicine pharmacogenetics in the clinic Adam Hedgecoe |
| title_full_unstemmed | The politics of personalised medicine pharmacogenetics in the clinic Adam Hedgecoe |
| title_short | The politics of personalised medicine |
| title_sort | the politics of personalised medicine pharmacogenetics in the clinic |
| title_sub | pharmacogenetics in the clinic |
| topic | Gesellschaft Pharmacogenetics / Social aspects Trastuzumab (DE-588)4661821-1 gnd Brustkrebs (DE-588)4008528-4 gnd Gesundheitspolitik (DE-588)4113743-7 gnd Soziologie (DE-588)4077624-4 gnd Medizin (DE-588)4038243-6 gnd Tacrin (DE-588)4415047-7 gnd Pharmakogenetik (DE-588)4271255-5 gnd Wissenschaftsentwicklung (DE-588)4079355-2 gnd Alzheimerkrankheit (DE-588)4112510-1 gnd |
| topic_facet | Gesellschaft Pharmacogenetics / Social aspects Trastuzumab Brustkrebs Gesundheitspolitik Soziologie Medizin Tacrin Pharmakogenetik Wissenschaftsentwicklung Alzheimerkrankheit |
| url | https://doi.org/10.1017/CBO9780511489136 |
| work_keys_str_mv | AT hedgecoeadam thepoliticsofpersonalisedmedicinepharmacogeneticsintheclinic |